Nektar Therapeutics [NKTR] Revenue clocked in at $90.12 million, up 138.94% YTD: What’s Next?
Nektar Therapeutics [NASDAQ: NKTR] stock went on a downward path that fall over -9.40% on Wednesday, amounting to a one-week price increase of more than 4.65%. Over the last 12 months, NKTR stock rose by 37.32%. The one-year Nektar Therapeutics stock forecast points to a